These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27723264)

  • 1. Target identification with quantitative activity based protein profiling (ABPP).
    Chen X; Wong YK; Wang J; Zhang J; Lee YM; Shen HM; Lin Q; Hua ZC
    Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 27723264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target identification of natural and traditional medicines with quantitative chemical proteomics approaches.
    Wang J; Gao L; Lee YM; Kalesh KA; Ong YS; Lim J; Jee JE; Sun H; Lee SS; Hua ZC; Lin Q
    Pharmacol Ther; 2016 Jun; 162():10-22. PubMed ID: 26808165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
    Li J; Wang G; Ye M; Qin H
    Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical proteomic strategies for the discovery and development of anticancer drugs.
    Liu Y; Guo M
    Proteomics; 2014 Mar; 14(4-5):399-411. PubMed ID: 24323546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation nucleolin as a target of curcumol in nasopharyngeal carcinoma cells.
    Wang J; Wu J; Li X; Liu H; Qin J; Bai Z; Chi B; Chen X
    J Proteomics; 2018 Jun; 182():1-11. PubMed ID: 29684682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Target Identification Using an iTRAQ-Based Quantitative Chemical Proteomics Approach-Based on a Target Profiling Study of Andrographolide.
    Wang J; Wong YK; Zhang J; Lee YM; Hua ZC; Shen HM; Lin Q
    Methods Enzymol; 2017; 586():291-309. PubMed ID: 28137568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in identification and validation of protein targets of natural products without chemical modification.
    Chang J; Kim Y; Kwon HJ
    Nat Prod Rep; 2016 May; 33(5):719-30. PubMed ID: 26964663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dimethyl-Labeling-Based Strategy for Site-Specifically Quantitative Chemical Proteomics.
    Yang F; Gao J; Che J; Jia G; Wang C
    Anal Chem; 2018 Aug; 90(15):9576-9582. PubMed ID: 29989794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in protein precipitation-based methods for drug-target screening].
    Liu T; Qin WJ; Yang HJ
    Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the targets of biologically active small molecules using quantitative proteomics.
    Vendrell-Navarro G; Brockmeyer A; Waldmann H; Janning P; Ziegler S
    Methods Mol Biol; 2015; 1263():263-86. PubMed ID: 25618352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
    Katayama H; Oda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP).
    Wang J; Zhang CJ; Zhang J; He Y; Lee YM; Chen S; Lim TK; Ng S; Shen HM; Lin Q
    Sci Rep; 2015 Jan; 5():7896. PubMed ID: 25600173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-based protein profiling: Recent advances in medicinal chemistry.
    Deng H; Lei Q; Wu Y; He Y; Li W
    Eur J Med Chem; 2020 Apr; 191():112151. PubMed ID: 32109778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.